Home › Funds › Invenomic Capital Management LP › CLVT
Invenomic Capital Management LP position in CLVT
CLARIVATE PLC · Technology
Invenomic Capital Management LP reported holding 14,261,471 shares of CLVT (CLARIVATE PLC) in its Q2 2026 13F filing — a position valued at US$30.8M, representing 1.84% of its reported portfolio and ranking #14 among its reported holdings. Invenomic Capital Management LP has disclosed CLVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's CLVT position evolved
Invenomic Capital Management LP first disclosed a stake in CLVT in Q3 2023 at 7,486,244 shares (US$50.2M). Across 12 filings, Invenomic Capital Management LP increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 14,261,471 shares valued at US$30.8M — an increase of 951,237 shares quarter over quarter.. Notable position changes include a 34% trim in Q4 2023 (shares fell 20% over the following quarter), a 29% increase in Q1 2024 (shares fell 23% over the following quarter), a 47% increase in Q1 2026 (shares fell 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7.49M | $50.23M | New |
| Q4 2023 | 4.96M | $45.92M | Reduce |
| Q1 2024 | 6.41M | $47.64M | Add |
| Q2 2024 | 6.75M | $38.43M | Add |
| Q3 2024 | 5.92M | $42.02M | Reduce |
| Q4 2024 | 6.59M | $33.46M | Add |
| Q1 2025 | 8.48M | $33.33M | Add |
| Q2 2025 | 9.39M | $40.36M | Add |
| Q3 2025 | 8.70M | $33.33M | Reduce |
| Q4 2025 | 9.03M | $30.16M | Add |
| Q1 2026 | 13.31M | $33.67M | Add |
| Q2 2026 | 14.26M | $30.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLVT and 13F data
CLVT (CLARIVATE PLC) is a Technology company. 12 other funds we track also report a position in CLVT — the largest reported positions include Leonard Green & Partners, L.P. (US$252.0M), Exor N.V. (US$145.4M), Clarkston Capital Partners, LLC (US$98.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLVT
- Leonard Green & Partners, L.P. 116.67M sh · $252.00M · Q2 2026
- Exor N.V. 67.29M sh · $145.36M · Q2 2026
- Clarkston Capital Partners, LLC 45.73M sh · $98.79M · Q2 2026
- Partners Group Holding AG 25.58M sh · $55.26M · Q2 2026
- Atairos Group, Inc. 12.26M sh · $26.48M · Q2 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held CLVT?
Invenomic Capital Management LP has disclosed CLVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Invenomic Capital Management LP's current position in CLVT?
As of Q2 2026, Invenomic Capital Management LP holds 14.26M shares of CLVT (CLARIVATE PLC), valued at $30.80M, representing 1.84% of its reported portfolio and ranking #14.
Has Invenomic Capital Management LP been buying or selling CLVT?
In the latest 13F filing (Q2 2026), Invenomic Capital Management LP increased its position in CLVT.
Which other funds hold CLVT?
Other major institutional holders of CLVT include Leonard Green & Partners, L.P., Exor N.V., Clarkston Capital Partners, LLC, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.